José Baselga Selected Research

José Baselga Research Topics

Disease

137	Neoplasms (Cancer) 04/2021 - 01/2002
129	Breast Neoplasms (Breast Cancer) 11/2021 - 02/2002
21	Disease Progression 01/2020 - 01/2002
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2002
12	Pathologic Complete Response 01/2019 - 12/2005
10	Diarrhea 01/2020 - 01/2012
10	Neoplasm Metastasis (Metastasis) 01/2016 - 02/2002
9	Triple Negative Breast Neoplasms 01/2019 - 03/2010
8	Exanthema (Rash) 01/2020 - 08/2005
6	Hyperglycemia 01/2020 - 04/2008
6	Carcinoma (Carcinomatosis) 01/2017 - 08/2002
6	Colorectal Neoplasms (Colorectal Cancer) 12/2015 - 06/2005
5	Neutropenia 10/2017 - 04/2008
5	Stomatitis 01/2017 - 04/2008
5	Squamous Cell Carcinoma of Head and Neck 01/2017 - 08/2005
3	Cardiotoxicity 04/2018 - 01/2009
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017 - 06/2015
3	Carcinogenesis 03/2016 - 10/2004
3	Lung Neoplasms (Lung Cancer) 10/2011 - 07/2002
3	Adenocarcinoma 12/2010 - 11/2005
2	Melanoma (Melanoma, Malignant) 01/2020 - 08/2015
2	Fatigue 01/2019 - 02/2012
2	Heart Failure 01/2019 - 01/2006
2	Vomiting 01/2019 - 11/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

51	Trastuzumab (Herceptin)FDA Link 01/2021 - 10/2004
42	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2002
31	human ERBB2 proteinIBA 01/2020 - 04/2005
25	Lapatinib (GW572016)FDA Link 01/2019 - 04/2007
22	Phosphotransferases (Kinase)IBA 04/2021 - 08/2004
22	Hormones (Hormone)IBA 01/2019 - 02/2002
21	Estrogen ReceptorsIBA 10/2020 - 12/2005
18	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2006
16	pertuzumabIBA 01/2021 - 03/2010
14	Monoclonal AntibodiesIBA 09/2017 - 01/2004
13	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
13	Everolimus FDA Link 01/2019 - 04/2008
13	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 08/2002
11	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2003
11	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 07/2013
10	Gefitinib (Iressa)FDA Link 01/2023 - 01/2002
10	Aromatase InhibitorsIBA 10/2020 - 02/2012
10	Cetuximab (Erbitux)FDA Link 01/2016 - 10/2004
10	Docetaxel (Taxotere)FDA Link 02/2015 - 02/2008
9	Fulvestrant (Faslodex)FDA Link 04/2021 - 04/2015
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2004
9	exemestane (Aromasin)FDA Link 01/2019 - 02/2012
9	Capecitabine (Xeloda)FDA Link 12/2017 - 10/2004
8	Mitogen-Activated Protein KinasesIBA 10/2018 - 10/2004
8	Epidermal Growth Factor (EGF)IBA 11/2017 - 10/2004
7	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2019 - 08/2007
7	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2011 - 04/2005
6	taxaneIBA 01/2020 - 08/2007
6	AlpelisibIBA 01/2019 - 07/2013
6	NVP-BKM120IBA 11/2018 - 01/2012
6	Estrogens (Estrogen)FDA Link 12/2017 - 09/2008
6	TOR Serine-Threonine KinasesIBA 10/2017 - 04/2008
6	Fluorouracil (Carac)FDA LinkGeneric 02/2017 - 10/2004
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2013 - 01/2002
5	Phenobarbital (Luminal)FDA Link 01/2020 - 03/2010
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 11/2012
5	LigandsIBA 01/2019 - 12/2010
5	ipatasertibIBA 10/2017 - 12/2013
5	Mechanistic Target of Rapamycin Complex 1IBA 01/2017 - 05/2012
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016 - 06/2013
4	capivasertibIBA 04/2021 - 07/2017
4	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2019 - 04/2016
4	PlatinumIBA 01/2019 - 08/2005
4	Sorafenib (BAY 43-9006)FDA Link 12/2017 - 05/2012
4	dalotuzumabIBA 10/2017 - 10/2011
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017 - 12/2005
4	ParaffinIBA 01/2017 - 04/2007
4	RNA (Ribonucleic Acid)IBA 03/2016 - 09/2011
4	AntibodiesIBA 03/2014 - 07/2006
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 12/2005
4	Growth Factor ReceptorsIBA 10/2007 - 01/2004
3	Cell-Free Nucleic AcidsIBA 01/2021 - 10/2016
3	neratinibIBA 01/2020 - 11/2014
3	VemurafenibIBA 01/2020 - 08/2015
3	olaparibIBA 12/2018 - 11/2012
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2018 - 01/2017
3	ridaforolimusIBA 10/2017 - 01/2015
3	Drug CombinationsIBA 08/2017 - 02/2015
3	Formaldehyde (Formol)FDA Link 01/2017 - 01/2014
3	Ado-Trastuzumab EmtansineIBA 01/2017 - 11/2012
3	Methotrexate (Mexate)FDA LinkGeneric 01/2014 - 12/2005
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2021 - 01/2016
2	ChromatinIBA 10/2020 - 01/2017
2	MicroRNAs (MicroRNA)IBA 02/2020 - 01/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 12/2017
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2019 - 01/2016
2	Letrozole (Femara)FDA LinkGeneric 01/2019 - 06/2009
2	antineoplaston A10 (A 10)IBA 01/2019 - 11/2012
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2018 - 11/2016

Therapy/Procedure

99	Therapeutics 01/2021 - 01/2002
22	Drug Therapy (Chemotherapy) 01/2021 - 01/2004
9	Neoadjuvant Therapy 02/2020 - 02/2009
5	Aftercare (After-Treatment) 01/2019 - 06/2007
3	Radiotherapy 01/2016 - 01/2004